Results 241 to 250 of about 7,530,865 (297)

Defect‐Engineered BiO2‐X Nanosheets Mediate Sono‐Thermomechanical ECM Remodeling for Hepatocellular Carcinoma Immunotherapy

open access: yesAdvanced Science, EarlyView.
Herein, an ultrasound‐responsive BiO2‐X/siFn1 nanoplatform is developed to overcome anti‐PD‐1 resistance in hepatocellular carcinoma. Upon ultrasound irradiation, the platform downregulates fibronectin expression, while its sonothermal effect softens the dense extracellular matrix and activates antitumor immunity in the tumor microenvironment, thereby ...
Huimin Tian   +10 more
wiley   +1 more source

Targeting the PHB2–ACSL3 Lipid‐Remodeling Axis Overcomes Cisplatin Resistance by Restoring Ferroptosis in Gastric Cancer

open access: yesAdvanced Science, EarlyView.
ABSTRACT Platinum‐based chemotherapy resistance remains a major obstacle in gastric cancer (GC) treatment. Through integrated transcriptomic profiling of cisplatin‐resistant xenografts and pharmacogenomic interrogation of the NCI‐60 dataset, we identified Prohibitin‐2 (PHB2) as a previously unrecognized determinant of chemoresistance.
Liang Xu   +10 more
wiley   +1 more source

Biochemical Profile at Residential Admission in Anorexia Nervosa: Comparable Findings Across Restricting and Binge-Purge Subtypes. [PDF]

open access: yesNutrients
Monaco F   +12 more
europepmc   +1 more source

Effects of pulsed electromagnetic therapy on the major hematological and biochemical parameters in horses. [PDF]

open access: yesJ Vet Med Sci
Pongrácz L   +6 more
europepmc   +1 more source

Etiological and immunological aspects of equine hoof canker. [PDF]

open access: yesVet Res Commun
Styková E   +5 more
europepmc   +1 more source

Liver Function Assessment in Oncology: Current Tools for Evaluating Hepatic Reserve and Surgical Decision-Making. [PDF]

open access: yesJ Clin Med
Caringi S   +9 more
europepmc   +1 more source

Route- and sex-dependent toxicity of clinical-stage silver nanoparticles in mice.

open access: yesNanoscale
Yeerkenbieke B   +15 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy